| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0168-8278(96)80195-4 |
| P698 | PubMed publication ID | 8834034 |
| P2093 | author name string | F Trevisani | |
| D H Van Thiel | |||
| A Colantoni | |||
| P Caraceni | |||
| P2860 | cites work | Liver histology in a 'normal' population--examinations of 503 consecutive fatal traffic casualties | Q28240872 |
| Primary nonfunction of hepatic allografts with preexisting fatty infiltration | Q34256918 | ||
| Evolution of liver transplantation | Q34275840 | ||
| Biologically active products of stimulated liver macrophages (Kupffer cells). | Q37893914 | ||
| Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation | Q40633279 | ||
| Regulation of fatty acid oxidation in heart | Q40814668 | ||
| Hepatic transplantation survival: correlation with adenine nucleotide level in donor liver | Q41428867 | ||
| Protective effects of prostaglandin E1 on normothermic liver ischemia | Q43908176 | ||
| Beneficial effect of iloprost on early pulmonary function after lung preservation with modified eurocollins solution | Q44804341 | ||
| The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation | Q45364287 | ||
| Acetylation of Tris(hydroxymethyl)aminomethane (Tris) and Tris derivatives by carnitine acetyltransferase | Q46929241 | ||
| The effect of prostaglandin E1 on heart preservation | Q67564812 | ||
| Effect of intraportal glucose infusion on hepatic glycogen content and degradation, and outcome of liver transplantation | Q67568233 | ||
| Adenine nucleotide metabolism and its relation to organ viability in human liver transplantation | Q68123926 | ||
| Treatment of primary liver graft nonfunction with prostaglandin E1 | Q69538675 | ||
| For how long can the liver tolerate ischaemia? | Q69617263 | ||
| Urinary excretion of carnitine and its derivatives in newborns | Q70364961 | ||
| A rat fatty liver transplant model | Q70665158 | ||
| Risk factors for primary dysfunction after liver transplantation--a multivariate analysis | Q70665180 | ||
| Frozen section evaluation of donor livers before transplantation | Q71605484 | ||
| Prediction of the outcome of transplantation in man by platelet adherence in donor liver allografts. Evidence of the importance of prepreservation injury | Q72092199 | ||
| The Many Facets of Reperfusion Injury | Q72114761 | ||
| New reactive oxidizing species causes formation of carbon-centered radical adducts in organic extracts of blood following liver transplantation | Q72150984 | ||
| Effect of L-carnitine on mitochondrial acyl CoA esters in the ischemic dog heart | Q72153900 | ||
| A new rat model for studies of the ischemic injury after transplantation of fatty livers: improvement after postoperative administration of prostaglandin | Q72243879 | ||
| Hepatic microcirculatory changes after reperfusion in fatty and normal liver transplantation in the rat | Q72628762 | ||
| Superoxide Release by Zymosan-Stimulated Rat Kupffer Cells in vitro | Q72929342 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 114-121 | |
| P577 | publication date | 1996-01-01 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | The use of donor fatty liver for liver transplantation: a challenge or a quagmire? | |
| P478 | volume | 24 |
| Q52566617 | A high-fat diet impairs liver regeneration in C57BL/6 mice through overexpression of the NF-kappaB inhibitor, IkappaBalpha. |
| Q36871971 | A silybin-phospholipids complex counteracts rat fatty liver degeneration and mitochondrial oxidative changes. |
| Q77632433 | Assessing risk of the use of livers with macro and microsteatosis in a liver transplant program |
| Q38484033 | Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation |
| Q34746272 | Diagnostic issues in liver transplantation pathology |
| Q34027975 | Expanding the donor pool for liver transplantation |
| Q51817319 | Hepatic steatosis in liver transplant donors: rare phenomenon or common feature of donor population? |
| Q47993755 | Hepatic steatosis: innocent bystander or guilty party? |
| Q50902071 | In defense of the reverence of all life: Heideggerean dissolution of the ethical challenges of organ donation after circulatory determination of death. |
| Q74616217 | Is a fatty liver dangerous for transplantation? |
| Q57014305 | Ischemia-reperfusion injury in a diet-induced rat fatty liver |
| Q43881994 | Ischemia-reperfusion injury in rat fatty liver: role of nutritional status |
| Q38146878 | Ischemia–reperfusion injury in patients with fatty liver and the clinical impact of steatotic liver on hepatic surgery |
| Q42114330 | Ischemic preconditioning increases the tolerance of Fatty liver to hepatic ischemia-reperfusion injury in the rat. |
| Q35941934 | Managing nonalcoholic fatty liver disease: recommendations for family physicians. |
| Q57011041 | Mitochondrial oxidative injury in rat fatty livers exposed to warm ischemia-reperfusion |
| Q35425408 | Non-heart beating organ donation: old procurement strategy--new ethical problems |
| Q81048507 | Nonalcoholic steatohepatitis |
| Q74681810 | P-selectin glycoprotein ligand-1 (rPSGL-Ig)-mediated blockade of CD62 selectin molecules protects rat steatotic liver grafts from ischemia/reperfusion injury |
| Q33874294 | Preservation injury of the liver: mechanisms and novel therapeutic strategies |
| Q43753094 | Protective role of bortezomib in steatotic liver ischemia/reperfusion injury through abrogation of MMP activation and YKL-40 expression. |
| Q46858906 | Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1. |
| Q34569517 | SIMPLE MACHINE PERFUSION SIGNIFICANTLY ENHANCES HEPATOCYTE YIELDS OF ISCHEMIC AND FRESH RAT LIVERS. |
| Q64986257 | Short-term and long-term outcomes of liver transplantation using moderately and severely steatotic donor livers: A systematic review. |
| Q43173972 | Short-term therapy with peroxisome proliferation-activator receptor-alpha agonist Wy-14,643 protects murine fatty liver against ischemia-reperfusion injury |
| Q36696488 | Steatosis as a risk factor in liver surgery |
| Q50522041 | The guanylate cyclase-coupled natriuretic peptide receptor: a new target for prevention of cold ischemia-reperfusion damage of the rat liver. |
| Q34410053 | The role of molecular chaperonins in warm ischemia and reperfusion injury in the steatotic liver: a proteomic study |
| Q73322528 | Use of older controlled non-heart-beating donors for liver transplantation |
Search more.